Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,430.61
(
-0.94%
)
US TECH 100
28,451.00
(
-1.18%
)
Dow Jones
49,657.83
(
-0.81%
)
Brent Oil
106.30
(
2.03%
)
Bitcoin
79,265.02
(
-2.21%
)
News Focus
News Focus
Post# of 257575
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ThomasS

Send PM Follow Ignore
Followers 12
Posts 2277
Boards Moderated 0
Alias Born 05/05/2005

ThomasS

Re: None

Friday, 08/01/2008 9:11:30 AM

Friday, August 01, 2008 9:11:30 AM

Post# of 257575
Teva(MNTA) As alluded to by Dew...

Teva-TEVA should benefit from BIIB/ELN's PML disclosure@COWN
Cowen said TEVA's Copaxone has continued to gain share as its efficacy profile has grown in the clinical community. Shares are Outperform rated.

"Illegitimacy is something we should talk about in terms of not having it."

- Dan Quayle

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today